Literature DB >> 23062691

Inhibition of P-glycoprotein enhances sensitivity of Caenorhabditis elegans to ivermectin.

Bernadette F Ardelli1, Roger K Prichard.   

Abstract

In vertebrates, the function of P-glycoprotein (PGP) is to protect against toxic compounds through active efflux of the toxin from target tissues. In clinical oncology, the overexpression of PGP confers drug resistance. The function(s) of PGP in nematode physiology or in conferring drug resistance is less understood. The objective of this study was to determine the role of PGP in drug resistance in nematodes using Caenorhabditis elegans and ivermectin (IVM) as the model system. The IVM sensitive wild-type Bristol N2 strain, seven PGP deletion strains and a triple IVM receptor (avr-14/avr-15/glc-1) knock-out strain showing synthetic resistance to IVM (IVM-R) were used to (1) compare the gene expression signatures of 15 PGPs in the wild-type and resistant strains following treatment; (2) measure motility and pharyngeal pumping phenotypes in the wild-type, IVM-R and PGP deletion strains before and after treatment; and (3) quantify the phenotypic responses of the wild-type and IVM-R strains to IVM or IVM co-administered with 12 chemosensitizers that interfere with PGP function. IVM induced changes in both amplitude and timing of gene expression for the 15 PGP genes. Following IVM treatment, the most significant effects were observed in the IVM-R strain for those PGP genes expressed in the neurons, pharynx and intestine. Inactivation of pgp-2, pgp-5, pgp-6, pgp-7, pgp-12 and pgp-13 resulted in increased sensitivity to IVM compared with the wild-type. The phenotypic responses of the IVM-R strain differed from those of the wild-type strain when exposed to IVM alone, or IVM co-administered with chemosensitizers. The phenotypic responses to the co-administration of chemosensitizers varied with the concentration of IVM used, suggesting that the action of PGP's is influenced by the concentration of IVM. Verapamil restored sensitivity to IVM in the IVM-R strain. Our results demonstrate that PGPs play a role in protecting C. elegans from IVM toxicity and inhibition of PGP enhances susceptibility to IVM. PGP may be a mechanism for multidrug resistance (MDR) in parasitic nematodes.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23062691     DOI: 10.1016/j.vetpar.2012.09.021

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  29 in total

1.  Acquired Tolerance to Ivermectin and Moxidectin after Drug Selection Pressure in the Nematode Caenorhabditis elegans.

Authors:  Cécile Ménez; Mélanie Alberich; Dalia Kansoh; Alexandra Blanchard; Anne Lespine
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

Review 2.  ABC multidrug transporters in schistosomes and other parasitic flatworms.

Authors:  Robert M Greenberg
Journal:  Parasitol Int       Date:  2013-03-06       Impact factor: 2.230

Review 3.  New approaches for understanding mechanisms of drug resistance in schistosomes.

Authors:  Robert M Greenberg
Journal:  Parasitology       Date:  2013-04-03       Impact factor: 3.234

4.  Transgenically expressed Parascaris P-glycoprotein-11 can modulate ivermectin susceptibility in Caenorhabditis elegans.

Authors:  I Jana I Janssen; Jürgen Krücken; Janina Demeler; Georg von Samson-Himmelstjerna
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-04-08       Impact factor: 4.077

5.  An opioid-like system regulating feeding behavior in C. elegans.

Authors:  Mi Cheong Cheong; Alexander B Artyukhin; Young-Jai You; Leon Avery
Journal:  Elife       Date:  2015-04-21       Impact factor: 8.140

6.  Macrocyclic lactones differ in interaction with recombinant P-glycoprotein 9 of the parasitic nematode Cylicocylus elongatus and ketoconazole in a yeast growth assay.

Authors:  Maximiliane Kaschny; Janina Demeler; I Jana I Janssen; Tetiana A Kuzmina; Bruno Besognet; Theo Kanellos; Dominique Kerboeuf; Georg von Samson-Himmelstjerna; Jürgen Krücken
Journal:  PLoS Pathog       Date:  2015-04-07       Impact factor: 6.823

Review 7.  Recent advances in candidate-gene and whole-genome approaches to the discovery of anthelmintic resistance markers and the description of drug/receptor interactions.

Authors:  Andrew C Kotze; Peter W Hunt; Philip Skuce; Georg von Samson-Himmelstjerna; Richard J Martin; Heinz Sager; Jürgen Krücken; Jane Hodgkinson; Anne Lespine; Aaron R Jex; John S Gilleard; Robin N Beech; Adrian J Wolstenholme; Janina Demeler; Alan P Robertson; Claude L Charvet; Cedric Neveu; Ronald Kaminsky; Lucien Rufener; Melanie Alberich; Cecile Menez; Roger K Prichard
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-08-13       Impact factor: 4.077

8.  The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype.

Authors:  António Pinto-Almeida; Tiago Mendes; Ana Armada; Silvana Belo; Emanuel Carrilho; Miguel Viveiros; Ana Afonso
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

9.  Haemonchus contortus P-glycoproteins interact with host eosinophil granules: a novel insight into the role of ABC transporters in host-parasite interaction.

Authors:  Mohamed Issouf; Fabrice Guégnard; Christine Koch; Yves Le Vern; Alexandra Blanchard-Letort; Hua Che; Robin N Beech; Dominique Kerboeuf; Cedric Neveu
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

10.  Comparative tissue pharmacokinetics and efficacy of moxidectin, abamectin and ivermectin in lambs infected with resistant nematodes: Impact of drug treatments on parasite P-glycoprotein expression.

Authors:  Mercedes Lloberas; Luis Alvarez; Carlos Entrocasso; Guillermo Virkel; Mariana Ballent; Laura Mate; Carlos Lanusse; Adrian Lifschitz
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-12-03       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.